Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.24.1.1.u2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended
Apr. 24, 2024
Mar. 31, 2024
Common share issued for services   30,926
Common stock value   $ 31,667
Mr. Lucido [Member] | Subsequent Event [Member]    
Description of owed the Company and Mr. Lucido entered into an exchange agreement whereby the parties agreed to exchange the total of $544,284 owed by the Company, including $426,558 accrued fees pursuant to his Board service, and $117,726 owed by BioCorRx Pharmaceuticals, for 460,477 shares of restricted Common Stock  
Owed to related party $ 544,284  
Restricted shares of common Stock 460,477  
Accrued fees $ 426,558  
Owed to BioCorRx Pharmaceuticals 117,726  
Ms Felix [Member] | Subsequent Event [Member]    
Owed to related party $ 265,000  
Common stock issued for services rendered, share 224,196